| High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma L Licitra, F Perrone, P Bossi, S Suardi, L Mariani, R Artusi, M Oggionni, ... Journal of Clinical Oncology 24 (36), 5630-5636, 2006 | 792 | 2006 |
| MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy S Elad, KKF Cheng, RV Lalla, N Yarom, C Hong, RM Logan, J Bowen, ... Cancer 126 (19), 4423-4431, 2020 | 379 | 2020 |
| Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical … RV Lalla, J Bowen, A Barasch, L Elting, J Epstein, DM Keefe, DB McGuire, ... Cancer 120 (10), 1453-61, 2014 | 317 | 2014 |
| Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines Y Zadik, PR Arany, ER Fregnani, P Bossi, HS Antunes, RJ Bensadoun, ... Supportive Care in Cancer 27, 3969-3983, 2019 | 294 | 2019 |
| Global cancer control: responding to the growing burden, rising costs and inequalities in access GW Prager, S Braga, B Bystricky, C Qvortrup, C Criscitiello, E Esin, ... ESMO open 3 (2), e000285, 2018 | 240 | 2018 |
| Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients DP Saunders, JB Epstein, S Elad, J Allemano, P Bossi, ... Supportive Care in Cancer 21, 3191-3207, 2013 | 229 | 2013 |
| Cetuximab in recurrent and/or metastatic salivary gland carcinomas: a phase II study LD Locati, P Bossi, F Perrone, P Potepan, F Crippa, L Mariani, P Casieri, ... Oral oncology 45 (7), 574-578, 2009 | 226 | 2009 |
| Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up P Bossi, AT Chan, L Licitra, A Trama, E Orlandi, EP Hui, J Halámková, ... Annals of Oncology 32 (4), 452-465, 2021 | 210 | 2021 |
| Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives M Aapro, P Bossi, A Dasari, L Fallowfield, P Gascón, M Geller, K Jordan, ... Supportive care in cancer 28, 4589-4612, 2020 | 203 | 2020 |
| Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines CHL Hong, LA Gueiros, JS Fulton, KKF Cheng, A Kandwal, D Galiti, ... Supportive care in cancer 27, 3949-3967, 2019 | 198 | 2019 |
| Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma S Pricl, B Cortelazzi, V Dal Col, D Marson, E Laurini, M Fermeglia, ... Molecular oncology 9 (2), 389-397, 2015 | 193 | 2015 |
| Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review P Strojan, JB Vermorken, JJ Beitler, NF Saba, M Haigentz Jr, P Bossi, ... Head & neck 38 (S1), E2151-E2158, 2016 | 190 | 2016 |
| Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma F Perrone, S Suardi, E Pastore, P Casieri, M Orsenigo, S Caramuta, ... Clinical cancer research 12 (22), 6643-6651, 2006 | 189 | 2006 |
| The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: a narrative review P Bossi, P Delrio, A Mascheroni, M Zanetti Nutrients 13 (6), 1980, 2021 | 183 | 2021 |
| Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. V De Sanctis, P Bossi, G Sanguineti, F Trippa, D Ferrari, A Bacigalupo, ... Critical reviews in oncology/hematology 100, 147-166, 2016 | 175 | 2016 |
| Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma P Bossi, C Resteghini, N Paielli, L Licitra, S Pilotti, F Perrone Oncotarget 7 (45), 74362, 2016 | 173 | 2016 |
| Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) LD Locati, F Perrone, M Losa, M Mela, P Casieri, M Orsenigo, ... Oral oncology 45 (11), 986-990, 2009 | 171 | 2009 |
| Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus A Schindler, N Denaro, EG Russi, N Pizzorni, P Bossi, A Merlotti, ... Critical reviews in oncology/hematology 96 (2), 372-384, 2015 | 155 | 2015 |
| Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines—part 1: vitamins, minerals, and … N Yarom, A Hovan, P Bossi, A Ariyawardana, SB Jensen, M Gobbo, ... Supportive Care in Cancer 27, 3997-4010, 2019 | 147 | 2019 |
| TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma F Perrone, P Bossi, B Cortelazzi, L Locati, P Quattrone, MA Pierotti, ... Journal of Clinical Oncology 28 (5), 761-766, 2010 | 146 | 2010 |
